Skip to main content
TipRanks
Go Ultimate75% OFF

Anxo Pharmaceutical Co., Ltd. (6677) Balance Sheet

Anxo Pharmaceutical Co., Ltd. Balance Sheet

Anxo Pharmaceutical Co., Ltd.'s total assets for Q2 2026 were NT$2.08B, an increase of 0.62% from the previous quarter. TW:6677 total liabilities were NT$978.62M for the fiscal quarter, a 2.08% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 2.07BNT$ 2.11BNT$ 2.22BNT$ 1.97BNT$ 1.92B
NT$ 958.70MNT$ 968.21MNT$ 1.02BNT$ 1.14BNT$ 1.09B
NT$ 1.11BNT$ 1.14BNT$ 1.20BNT$ 829.64MNT$ 831.94M

Currency in TWD

Anxo Pharmaceutical Co., Ltd. Liabilities to Assets

0800M1.6B2.4B40 %50 %60 %70 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets